# Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System

> **NCT01121510** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **CardioDex** · enrollment: 50 (estimated)

## Conditions studied

- Coagulation
- Therapeutic Uses
- Pharmacologic Actions

## Interventions

- **DEVICE:** closure device

## Key facts

- **NCT ID:** NCT01121510
- **Lead sponsor:** CardioDex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05
- **Primary completion:** 2010-07
- **Final completion:** 2011-05
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** medical center difficulties in recruiting patients for the study in a timely fashion
- **Last updated:** 2010-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121510, "Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01121510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*